A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Researchers at Indiana University and Wuhan University in China have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building ...

REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma ...

Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

IPC Indice de Precios Y Cotizaciones 52,672.42-428.41-0.81% ...

After hours: March 24 at 6:23:25 PM EDT Loading Chart for AMLX ...

After hours: March 21 at 7:08:45 PM EDT Loading Chart for RYTM ...

Biopharmaceutical company developing drugs for neurological disorders.

Delivering late stage therapeutic pipeline, building the next generation of radiopharmaceuticals, growing industry leading precision medicine business, expanding global infrastructure for product ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...